Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab

被引：53

作者：

Schmidt, E

Benoit, S

Bröcker, EB

Zillikens, D

Goebeler, M

机构：

[1] Univ Heidelberg, Univ Hosp Mannheim, Dept Dermatol, D-68135 Mannheim, Germany

[2] Univ Wurzburg, Wurzburg, Germany

[3] Univ Lubeck, Lubeck, Germany

来源：

ARCHIVES OF DERMATOLOGY | 2006年 / 142卷 / 02期

关键词：

D O I：

10.1001/archderm.142.2.147

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：147 / 150

页数：4

共 19 条

[1] INCIDENCE AND DISTRIBUTION OF SUBEPIDERMAL AUTOIMMUNE BULLOUS SKIN DISEASES IN 3 FRENCH REGIONS [J].

BERNARD, P ;

VAILLANT, L ;

LABEILLE, B ;

BEDANE, C ;

ARBEILLE, B ;

DENOEUX, JP ;

LORETTE, G ;

BONNETBLANC, JM ;

PROST, C .

ARCHIVES OF DERMATOLOGY, 1995, 131 (01) :48-52

[2]

Borradori L, 2001, ARCH DERMATOL, V137, P269

[3] Mechanism of action of rituximab [J].

Cerny, T ;

Borisch, B ;

Introna, M ;

Johnson, P ;

Rose, AL .

ANTI-CANCER DRUGS, 2002, 13 :S3-S10

[4] Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody) [J].

Dupuy, A ;

Viguier, M ;

Bédane, C ;

Cordoliani, F ;

Blaise, S ;

Aucouturier, F ;

Bonnetblanc, JM ;

Morel, P ;

Dubertret, L ;

Bachelez, H .

ARCHIVES OF DERMATOLOGY, 2004, 140 (01) :91-96

[5] Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[6] Emerging treatment for epidermolysis bullosa acquisita [J].

Engineer, L ;

Ahmed, AR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (05) :818-828

[7] Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab [J].

Goebeler, M ;

Herzog, S ;

Bröcker, EB ;

Zillikens, D .

BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (04) :899-901

[8]

Goebeler Matthias, 2004, J Dtsch Dermatol Ges, V2, P774, DOI 10.1046/j.1439-0353.2004.04702.x-i1

[9] Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins [J].

Herzog, S ;

Schmidt, E ;

Goebeler, M ;

Bröcker, EB ;

Zillikens, D .

ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) :48-52

[10] MOLECULAR MECHANISMS REGULATING CD19, CD20 AND CD22 GENE-EXPRESSION [J].

KEHRL, JH ;

RIVA, A ;

WILSON, GL ;

THEVENIN, C .

IMMUNOLOGY TODAY, 1994, 15 (09) :432-436

← 1 2 →